IBM (IBM) director reports 338 deferred Promised Fee Shares in Form 4
Rhea-AI Filing Summary
International Business Machines Corp. director equity update: A director of IBM filed a Form 4 reporting a deferred compensation transaction dated 12/31/2025. The filing shows the director acquired 338 "Promised Fee Shares" at an exercise price of $0.00 under the IBM Board of Directors Deferred Compensation and Equity Award Plan, representing 338 shares of IBM common stock underlying the derivative security.
These Promised Fee Shares reflect a deferral of board fees into stock-based units rather than a market purchase or sale of IBM shares. Following this transaction, the director beneficially owned 31,422 derivative securities directly. Under the plan, payout or distribution of these Promised Fee Shares is deferred until the director’s retirement and can be settled in IBM common stock or cash.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Promised Fee Share | 338 | $296.21 | $100K |
Footnotes (1)
- Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.
FAQ
What insider transaction did IBM (IBM) report in this Form 4?
The Form 4 reports that an IBM director acquired 338 Promised Fee Shares on 12/31/2025 under the IBM Board of Directors Deferred Compensation and Equity Award Plan.
Did the IBM director buy or sell common stock on the open market?
No. The reported activity involves Promised Fee Shares from deferring board fees under a compensation plan, not an open-market purchase or sale of IBM common stock.